Wednesday, December 4, 2024
Wednesday |
Thursday |
Friday |
Saturday |
Sunday |
Monday |
Tuesday |
Wednesday |
Thursday |
Friday |
top
9:00 AM-11:55 PM
Thursday, December 5, 2024
Wednesday |
Thursday |
Friday |
Saturday |
Sunday |
Monday |
Tuesday |
Wednesday |
Thursday |
Friday |
top
1:00 AM-11:55 PM
5:30 AM-10:00 PM
3:00 PM-7:00 PM
Friday, December 6, 2024
Wednesday |
Thursday |
Friday |
Saturday |
Sunday |
Monday |
Tuesday |
Wednesday |
Thursday |
Friday |
top
5:30 AM-10:00 PM
7:00 AM-10:00 AM
7:00 AM-6:00 PM
9:00 AM-12:00 PM
11:00 AM-2:00 PM
Application of Evolving Evidence in Mantle Cell Lymphoma: Therapeutic Strategies Using BTK Inhibitors
Friday Satellite Symposia
Emerging insights in biology and treatment approaches to Peripheral T cell Lymphomas
Friday Satellite Symposia
Escape the Amyloid Maze: Unraveling Data and Care Strategies for AL Amyloidosis
Friday Satellite Symposia
Guiding Our Patient's Path: Managing First Relapse in Diffuse Large B-Cell Lymphoma Outside of CAR Ts
Friday Satellite Symposia
Treatment Crossroads: Diverse Perspectives on Treatment Strategies for Relapsed/Refractory DLBCL and FL
Friday Satellite Symposia
2:00 PM-5:00 PM
Scientific Workshops
3:00 PM-6:00 PM
Bispecific Antibodies: A Playbook for Relapsed/Refractory Follicular Lymphoma
Friday Satellite Symposia
Clinical assessment of gene therapies for hemophilia A and hemophilia B: Key takeaways for your practice
Friday Satellite Symposia
Collaboration In Chronic ITP: Improving Quality Of Life And Patient Outcomes
Friday Satellite Symposia
Complex Cases in the Community Clinic: Managing Diverse Hematologic Malignancies
Friday Satellite Symposia
7:00 PM-10:00 PM
How We Do It®: New Combinations Reshaping Treatment Decision-Making in Newly Diagnosed Multiple Myeloma
Friday Satellite Symposia
Saturday, December 7, 2024
Wednesday |
Thursday |
Friday |
Saturday |
Sunday |
Monday |
Tuesday |
Wednesday |
Thursday |
Friday |
top
7:00 AM-7:45 AM
7:00 AM-6:00 PM
8:00 AM-9:00 AM
9:00 AM-9:30 AM
9:00 AM-7:30 PM
9:05 AM-9:15 AM
9:15 AM-9:25 AM
9:30 AM-10:45 AM
9:30 AM-11:00 AM
602. Myeloid Oncogenesis: Basic: Cellular Mechanisms and Therapeutic Strategies
Oral and Poster Abstracts
603. Lymphoid Oncogenesis: Basic: Molecular Insights into Lymphomas and CLL
Oral and Poster Abstracts
ASH Clinical Practice Guidelines on Pediatric Venous Thromboembolism (VTE)
Special-Interest Sessions
11:00 AM-11:30 AM
11:00 AM-12:30 PM
11:00 AM-5:00 PM
11:05 AM-11:15 AM
11:15 AM-12:15 PM
11:20 AM-11:30 AM
11:30 AM-12:30 PM
11:35 AM-11:45 AM
12:00 PM-1:30 PM
12:30 PM-1:30 PM
1:30 PM-1:45 PM
1:30 PM-2:00 PM
1:35 PM-1:45 PM
1:45 PM-1:55 PM
1:45 PM-2:00 PM
2:00 PM-3:15 PM
2:00 PM-3:30 PM
503. Clonal Hematopoiesis, Aging, and Inflammation: Mechanisms of Hematopoietic Aging and Inflammation
Oral and Poster Abstracts
603. Lymphoid Oncogenesis: Basic: Molecular Insights into Acute Lymphoblastic Leukemias
Oral and Poster Abstracts
616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Menin Inhibitors in AML
Oral and Poster Abstracts
701. Experimental Transplantation: Basic and Translational: GVHD, Mucosal Immunology and the Microbiome
Oral and Poster Abstracts
907. Outcomes Research: Plasma Cell Disorders: Quality Matters and Key Outcomes in Multiple Myeloma
Oral and Poster Abstracts
3:30 PM-3:45 PM
3:30 PM-4:00 PM
3:35 PM-3:45 PM
3:45 PM-3:55 PM
3:45 PM-4:00 PM
4:00 PM-5:15 PM
4:00 PM-5:30 PM
332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Thrombosis in Pregnancy and Childhood
Oral and Poster Abstracts
622. Lymphomas: Translational - Non-Genetic: Novel Immune Evasion Strategies in B Cell Lymphomas
Oral and Poster Abstracts
637. Myelodysplastic Syndromes: Clinical and Epidemiological: Defining and Treating Low Risk MDS
Oral and Poster Abstracts
702. CAR-T Cell Therapies: Basic and Translational: Myeloid Biology and CAR-T Cells
Oral and Poster Abstracts
Artificial Intelligence in Hematology: From Generative AI to Ethics and Applications
Special-Interest Sessions
4:00 PM-5:35 PM
5:30 PM-7:30 PM
203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster I
Oral and Poster Abstracts
311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster I
Oral and Poster Abstracts
330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster I
Oral and Poster Abstracts
331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster I
Oral and Poster Abstracts
332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster I
Oral and Poster Abstracts
501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational: Poster I
Oral and Poster Abstracts
509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster I
Oral and Poster Abstracts
604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster I
Oral and Poster Abstracts
605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster I
Oral and Poster Abstracts
612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster I
Oral and Poster Abstracts
613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster I
Oral and Poster Abstracts
616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster I
Oral and Poster Abstracts
618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster I
Oral and Poster Abstracts
625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster I
Oral and Poster Abstracts
631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster I
Oral and Poster Abstracts
651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster I
Oral and Poster Abstracts
703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Poster I
Oral and Poster Abstracts
704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster I
Oral and Poster Abstracts
721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster I
Oral and Poster Abstracts
722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster I
Oral and Poster Abstracts
723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster I
Oral and Poster Abstracts
732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster I
Oral and Poster Abstracts
803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster I
Oral and Poster Abstracts
900. Health Services and Quality Improvement: Hemoglobinopathies: Poster I
Oral and Poster Abstracts
902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster I
Oral and Poster Abstracts
903. Health Services and Quality Improvement: Myeloid Malignancies: Poster I
Oral and Poster Abstracts
905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I
Oral and Poster Abstracts
906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster I
Oral and Poster Abstracts
6:00 PM-9:00 PM
Hematology Inclusion Pathway (HIP) Oral Presentations - Classical Hematology
Special-Interest Sessions
Hematology Inclusion Pathway (HIP) Oral Presentations - Health Services Outcomes
Special-Interest Sessions
Hematology Inclusion Pathway (HIP) Oral Presentations - Malignant Hematology
Special-Interest Sessions
8:00 PM-9:00 PM
Sunday, December 8, 2024
Wednesday |
Thursday |
Friday |
Saturday |
Sunday |
Monday |
Tuesday |
Wednesday |
Thursday |
Friday |
top
7:00 AM-9:00 AM
7:00 AM-5:00 PM
7:00 AM-6:00 PM
7:30 AM-9:30 AM
8:00 AM-9:00 AM
9:00 AM-9:30 AM
9:00 AM-8:00 PM
9:05 AM-9:15 AM
9:15 AM-9:25 AM
9:30 AM-10:45 AM
9:30 AM-11:00 AM
321. Coagulation and Fibrinolysis: Basic and Translational. A Coagulation Grab Bag
Oral and Poster Abstracts
ASH Clinical Practice Guidelines on Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults
Special-Interest Sessions
Health Equity Symposium: Race, Structural Racism and the Social Determinants of Health in Hematology
Special-Interest Sessions
9:30 AM-11:05 AM
10:00 AM-5:00 PM
11:00 AM-11:30 AM
11:00 AM-12:30 PM
11:05 AM-11:15 AM
11:15 AM-12:15 PM
Trainee Didactic Session: Creating a Laboratory and Clinical Research Program from Scratch
Trainee Activities and Services
11:15 AM-12:30 PM
11:20 AM-11:30 AM
11:30 AM-12:30 PM
11:35 AM-11:45 AM
12:00 PM-1:30 PM
101. Red Cells and Erythropoiesis, Excluding Iron: Regulation of Erythropoiesis
Oral and Poster Abstracts
311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Big Data and Basic Science
Oral and Poster Abstracts
506. Bone Marrow Microenvironment: The Bone Marrow Microenvironment in Normal Hematopoiesis
Oral and Poster Abstracts
624. Hodgkin Lymphomas: Clinical and Epidemiological: Optimization of Therapy
Oral and Poster Abstracts
626. Aggressive Lymphomas: Clinical and Epidemiological: Challenging Subtypes of Aggressive Lymphomas
Oral and Poster Abstracts
627. Aggressive Lymphomas: Pharmacologic Therapies: New R-CHOP Combinations for Treatment Naïve DLBCL
Oral and Poster Abstracts
642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Mutations, Prognosis and MRD in CLL
Oral and Poster Abstracts
12:30 PM-1:30 PM
1:30 PM-2:00 PM
1:30 PM-4:00 PM
Simulcast of Announcement of Awards and Plenary Scientific Session (for in-person participants)
Special-Interest Sessions
Simulcast of Announcement of Awards and Plenary Scientific Session (for in-person participants)
Special-Interest Sessions
Simulcast of Announcement of Awards and Plenary Scientific Session (for in-person participants)
Special-Interest Sessions
Simulcast of Announcement of Awards and Plenary Scientific Session (for in-person participants)
Special-Interest Sessions
2:00 PM-4:00 PM
4:00 PM-4:30 PM
4:05 PM-4:15 PM
4:15 PM-4:25 PM
4:30 PM-5:45 PM
4:30 PM-6:00 PM
637. Myelodysplastic Syndromes: Clinical and Epidemiological: Treatment and Prognostication of MDS
Oral and Poster Abstracts
654. Multiple Myeloma: Pharmacologic Therapies: Optimizing Therapy in Newly Diagnosed Myeloma and Beyond
Oral and Poster Abstracts
907. Outcomes Research: Plasma Cell Disorders: Frailty, Supportive Care, and Factors Impacting Outcomes
Oral and Poster Abstracts
4:30 PM-6:30 PM
6:00 PM-8:00 PM
203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II
Oral and Poster Abstracts
311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster II
Oral and Poster Abstracts
330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster II
Oral and Poster Abstracts
331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster II
Oral and Poster Abstracts
332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster II
Oral and Poster Abstracts
501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational: Poster II
Oral and Poster Abstracts
509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster II
Oral and Poster Abstracts
604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster II
Oral and Poster Abstracts
605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster II
Oral and Poster Abstracts
612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster II
Oral and Poster Abstracts
613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster II
Oral and Poster Abstracts
616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster II
Oral and Poster Abstracts
618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster II
Oral and Poster Abstracts
625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster II
Oral and Poster Abstracts
631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster II
Oral and Poster Abstracts
634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster II
Oral and Poster Abstracts
642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster II
Oral and Poster Abstracts
651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster II
Oral and Poster Abstracts
703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Poster II
Oral and Poster Abstracts
704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster II
Oral and Poster Abstracts
721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster II
Oral and Poster Abstracts
722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster II
Oral and Poster Abstracts
723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster II
Oral and Poster Abstracts
732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster II
Oral and Poster Abstracts
803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster II
Oral and Poster Abstracts
900. Health Services and Quality Improvement: Hemoglobinopathies: Poster II
Oral and Poster Abstracts
902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster II
Oral and Poster Abstracts
903. Health Services and Quality Improvement: Myeloid Malignancies: Poster II
Oral and Poster Abstracts
905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II
Oral and Poster Abstracts
906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster II
Oral and Poster Abstracts
Monday, December 9, 2024
Wednesday |
Thursday |
Friday |
Saturday |
Sunday |
Monday |
Tuesday |
Wednesday |
Thursday |
Friday |
top
7:00 AM-7:45 AM
7:00 AM-5:00 PM
7:00 AM-6:00 PM
7:30 AM-8:30 AM
8:00 AM-9:00 AM
8:15 AM-8:45 AM
8:30 AM-9:00 AM
9:00 AM-10:00 AM
9:00 AM-8:00 PM
10:00 AM-10:30 AM
Best Practices for Peer Review: ASH Clinical News interviews the Blood Advances Editors
Blood Journals Studio
10:00 AM-2:00 PM
10:05 AM-10:15 AM
10:15 AM-10:25 AM
10:30 AM-11:45 AM
10:30 AM-12:00 PM
311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Clinical Evidence in ITP
Oral and Poster Abstracts
12:00 PM-12:30 PM
The ABCs of Publishing for Authors: The Hematologist interviews the Blood Editors
Blood Journals Studio
12:00 PM-1:15 PM
12:00 PM-1:30 PM
12:05 PM-12:15 PM
12:15 PM-1:15 PM
Trainee Didactic Session: Building, Nurturing, and Sustaining a Research Program
Trainee Activities and Services
Trainee Didactic Session: Setting up a Health Services and Outcomes Research Program
Trainee Activities and Services
12:20 PM-12:30 PM
12:30 PM-1:30 PM
12:35 PM-12:45 PM
1:00 PM-1:30 PM
1:30 PM-2:30 PM
2:30 PM-2:45 PM
2:35 PM-2:45 PM
2:45 PM-4:00 PM
2:45 PM-4:15 PM
201. Granulocytes, Monocytes, and Macrophages: From Inflammation to Hemophagocytic Lymphohistiocytosis
Oral and Poster Abstracts
506. Bone Marrow Microenvironment: The Bone Marrow Microenvironment in Disease
Oral and Poster Abstracts
604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: New Targets and Drugs
Oral and Poster Abstracts
615. Acute Myeloid Leukemias: Clinical and Epidemiological: Genetic Markers and Outcomes in AML
Oral and Poster Abstracts
627. Aggressive Lymphomas: Pharmacologic Therapies: Novel Monotherapies or Novel Disease Indications
Oral and Poster Abstracts
701. Experimental Transplantation: Basic and Translational: GVHD, GVL and Alloimmunity
Oral and Poster Abstracts
4:30 PM-5:45 PM
4:30 PM-6:00 PM
101. Red Cells and Erythropoiesis, Excluding Iron: Erythropoiesis in Disease
Oral and Poster Abstracts
503. Clonal Hematopoiesis, Aging, and Inflammation: Causes and Consequences
Oral and Poster Abstracts
622. Lymphomas: Translational - Non-Genetic: New Approaches and Models for Improving Lymphoma Therapies
Oral and Poster Abstracts
642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Frontline Targeted Therapy Combinations
Oral and Poster Abstracts
655. Multiple Myeloma: Cellular Therapies: Unleashing Cell Therapies Against Myeloma
Oral and Poster Abstracts
801. Gene Therapies: Gene Therapies for Hemophilia, Cancer and Immunodeficiencies
Oral and Poster Abstracts
6:00 PM-7:30 PM
6:00 PM-8:00 PM
203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster III
Oral and Poster Abstracts
311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster III
Oral and Poster Abstracts
330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster III
Oral and Poster Abstracts
331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster III
Oral and Poster Abstracts
332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster III
Oral and Poster Abstracts
501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational: Poster III
Oral and Poster Abstracts
509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster III
Oral and Poster Abstracts
604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster III
Oral and Poster Abstracts
605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster III
Oral and Poster Abstracts
612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster III
Oral and Poster Abstracts
613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster III
Oral and Poster Abstracts
616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster III
Oral and Poster Abstracts
617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster III
Oral and Poster Abstracts
618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster III
Oral and Poster Abstracts
625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster III
Oral and Poster Abstracts
631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster III
Oral and Poster Abstracts
634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III
Oral and Poster Abstracts
642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster III
Oral and Poster Abstracts
651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster III
Oral and Poster Abstracts
703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Poster III
Oral and Poster Abstracts
704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster III
Oral and Poster Abstracts
721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster III
Oral and Poster Abstracts
722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster III
Oral and Poster Abstracts
723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster III
Oral and Poster Abstracts
732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster III
Oral and Poster Abstracts
803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster III
Oral and Poster Abstracts
900. Health Services and Quality Improvement: Hemoglobinopathies: Poster III
Oral and Poster Abstracts
902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster III
Oral and Poster Abstracts
903. Health Services and Quality Improvement: Myeloid Malignancies: Poster III
Oral and Poster Abstracts
905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III
Oral and Poster Abstracts
906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster III
Oral and Poster Abstracts
7:30 PM-9:30 PM
Tuesday, December 10, 2024
Wednesday |
Thursday |
Friday |
Saturday |
Sunday |
Monday |
Tuesday |
Wednesday |
Thursday |
Friday |
top
7:00 AM-1:30 PM
7:00 AM-2:45 PM
7:30 AM-9:00 AM
8:15 AM-11:00 AM
9:30 AM-9:45 AM
9:45 AM-11:15 AM
11:15 AM-11:30 AM
11:30 AM-1:00 PM
Wednesday, December 11, 2024
Wednesday |
Thursday |
Friday |
Saturday |
Sunday |
Monday |
Tuesday |
Wednesday |
Thursday |
Friday |
top
1:00 AM-11:55 PM
10:00 AM-11:00 AM
5:00 PM-6:00 PM
Thursday, December 12, 2024
Wednesday |
Thursday |
Friday |
Saturday |
Sunday |
Monday |
Tuesday |
Wednesday |
Thursday |
Friday |
top
1:00 AM-11:55 PM
Friday, December 13, 2024
Wednesday |
Thursday |
Friday |
Saturday |
Sunday |
Monday |
Tuesday |
Wednesday |
Thursday |
Friday |
top